Literature DB >> 33334959

Long-term treatment outcomes in a First Nations high school population with opioid use disorder.

Anita Srivastava1, Meldon Mayer Kahan2, Mae Katt3, Tammy Patriquin4, Henry Becker5, Alison McAndrew6, Colleen McCreery7, Claudette Chase8.   

Abstract

OBJECTIVE: To assess for long-term positive effects of buprenorphine treatment (BT) on opioid use disorder (OUD) at a Nishnawbe Aski Nation high school clinic.
DESIGN: Postgraduation telephone survey of high school students between March 2017 and January 2018.
SETTING: Dennis Franklin Cromarty High School in Thunder Bay, Ont. PARTICIPANTS: All 44 students who had received BT in the high school clinic during its operation from 2011 to 2013 were eligible to participate. MAIN OUTCOME MEASURES: Current substance use, BT status, and social and employment status.
RESULTS: Thirty-eight of the 44 students who had received BT in the high school clinic were located and approached; 32 consented to participate in the survey. A descriptive analysis of the surveyed indicators was undertaken. Almost two-thirds (n = 20, 62.5%) of the cohort had graduated from high school, more than one-third (n = 12, 37.5%) were employed full time, and most (n = 29, 90.6%) rated their health as "good" or "OK." A greater percentage of participants who continued taking BT after high school (n = 19, 61.3%) were employed full time (n = 8, 42.1% vs n = 4, 33.3%) and were abstinent from alcohol (n = 12, 63.2% vs n = 4, 33.3%). Participants still taking BT were significantly more likely to have obtained addiction counseling in the past year than those participants not in treatment (n = 9, 47.4% vs n = 1, 8.3%; P = .0464).
CONCLUSION: The study results suggest that offering OUD treatment to youth in the form of BT in a high school clinic might be an effective strategy for promoting positive long-term health and social outcomes. Clinical treatment guidelines currently recommend long-term opioid agonist treatment as the treatment of choice for OUD in the general population; they should consider adding youth to the population that might also benefit.
Copyright © the College of Family Physicians of Canada.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33334959      PMCID: PMC7745942          DOI: 10.46747/cfp.6612907

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  7 in total

1.  Prescription drug abuse rising among Aboriginal youths.

Authors:  Paul Christopher Webster
Journal:  CMAJ       Date:  2012-08-07       Impact factor: 8.262

2.  Hope in Fort Hope: First Nations community is winning the battle against prescription drug abuse.

Authors:  Fatima Uddin
Journal:  Can Fam Physician       Date:  2013-04       Impact factor: 3.275

3.  Extended vs short-term buprenorphine-naloxone for treatment of opioid-addicted youth: a randomized trial.

Authors:  George E Woody; Sabrina A Poole; Geetha Subramaniam; Karen Dugosh; Michael Bogenschutz; Patrick Abbott; Ashwin Patkar; Mark Publicker; Karen McCain; Jennifer Sharpe Potter; Robert Forman; Victoria Vetter; Laura McNicholas; Jack Blaine; Kevin G Lynch; Paul Fudala
Journal:  JAMA       Date:  2008-11-05       Impact factor: 56.272

Review 4.  Treatment of opioid-dependent adolescents and young adults with buprenorphine.

Authors:  Geetha A Subramaniam; Marc J Fishman; George Woody
Journal:  Curr Psychiatry Rep       Date:  2009-10       Impact factor: 5.285

5.  Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption--II.

Authors:  J B Saunders; O G Aasland; T F Babor; J R de la Fuente; M Grant
Journal:  Addiction       Date:  1993-06       Impact factor: 6.526

Review 6.  Maintenance treatments for opiate dependent adolescent.

Authors:  Silvia Minozzi; Laura Amato; Marina Davoli
Journal:  Cochrane Database Syst Rev       Date:  2009-04-15

7.  A retrospective study of retention of opioid-dependent adolescents and young adults in an outpatient buprenorphine/naloxone clinic.

Authors:  Steven C Matson; Gerrit Hobson; Mahmoud Abdel-Rasoul; Andrea E Bonny
Journal:  J Addict Med       Date:  2014 May-Jun       Impact factor: 3.702

  7 in total
  1 in total

Review 1.  Barriers and facilitators to opioid agonist therapy in rural and remote communities in Canada: an integrative review.

Authors:  Em M Pijl; Abeer Alraja; Elsie Duff; Carol Cooke; Stephen Dash; Nichole Nayak; Jesse Lamoureux; Ginette Poulin; Erin Knight; Ben Fry
Journal:  Subst Abuse Treat Prev Policy       Date:  2022-08-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.